Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
BEDFORD, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, 'Ocular” or the 'Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to twelve newly hired non-executive employees. The awards were made as an inducement material to each recipient’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
Ähnliche Seiten
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/05/tmt-newswire/globenewswire/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2335412ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/03/18/tmt-newswire/globenewswire/imagenebio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2302254Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/04/04/tmt-newswire/globenewswire/anika-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2314165Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/09/tmt-newswire/globenewswire/arcutis-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2339779Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/09/tmt-newswire/globenewswire/fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2339812